Congenica Appoints Kamraan Shariff as Chief Business Development Officer

Read More

Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants

Read More

David Atkins joins the National Genomics Board as BIA representative

Read More

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Read More

Congenica Contributes to Key Priority within UK Rare Disease Framework

Read More

Congenica Launches Patient Advocacy and Engagement Advisory Board

Read More

Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China

Read More

2020 – The Year of Healthcare Heroes and International Teamwork

Read More

Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification

Read More

Inclusion in AJHG “Year in Review” 2020

Read More

Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer

Read More

Congenica Appoints Kamraan Shariff as Chief Business Development Officer

Read More

Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants

Read More

David Atkins joins the National Genomics Board as BIA representative

Read More

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Read More

Congenica Contributes to Key Priority within UK Rare Disease Framework

Read More

Congenica Launches Patient Advocacy and Engagement Advisory Board

Read More

Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China

Read More

2020 – The Year of Healthcare Heroes and International Teamwork

Read More

Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification

Read More

Inclusion in AJHG “Year in Review” 2020

Read More

Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer

Read More